[The efficacy of hepatotropic agent Remaxol in oncological patients with postoperative liver dysfunction]

Autor:	A E, Karelov, I V, Pyshnaia, M V, Mitrokhina, I V, Popel', L V, Gorokhov, E G, Kremzel', E V, Naperov, A A, Nikolaev
Rok vydání:	2013
Předmět:	Male S-Adenosylmethionine L-Lactate Dehydrogenase Abdominal Cavity Alanine Transaminase Bilirubin Succinates Recovery of Function Middle Aged Alkaline Phosphatase Treatment Outcome Liver Liver Function Tests Neoplasms Humans Female Aspartate Aminotransferases Postoperative Period Aged
Zdroj:	Eksperimental'naia i klinicheskaia farmakologiia. 76(7)
ISSN:	0869-2092
Popis:	The study of the efficiency and safety of the hepatotropic drug Remaxol in oncological patients with minimal, subclinical manifestations of liver dysfunction in the postoperative period was performed. It is shown that using of Remaxolcontributes to leveling the biochemical liver dysfunction: decrease of the concentration of total bilirubin, a decrease serum activity of lactate dehydrogenase, alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase. The unwanted effects of Remaxol were not identified.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::ae4986eb862b105a321873bdeab79a06 https://pubmed.ncbi.nlm.nih.gov/24006611 Zobrazit plný text záznamu